Comparison of <i>Helicobacter pylori</i> in hospitalized <scp>COVID</scp>‐19 patients with and without gastrointestinal symptoms
The prevalence of <i>Helicobacter pylori</i> infection in patients with COVID-19, who have gastrointestinal symptoms, is high and should be considered as a treatment criterion for people infected with COVID-19.
Authors
- Rasoul Raesi (ORCID: https://orcid.org/0000-0002-5998-5209)
- Kiavash Hushmandi (ORCID: https://orcid.org/0000-0001-5682-5392)
- Asma Amiri Domari
- Salman Daneshi (ORCID: https://orcid.org/0000-0002-9199-0382)
- Amin Saeedi (ORCID: https://orcid.org/0000-0002-5853-9063)
- Shiva Kargar
- Mohammadhossein Gholamzadeh
- Afshin Mohammad Bagheri
Institutions
- Baqiyatallah University of Medical Sciences (IR)
- University of Jiroft (IR)
- Mashhad University of Medical Sciences (IR)
- Imam Khomeini Hospital (IR)
- Torbat Heydarieh University of Medical Sciences (IR)
- Zahedan University of Medical Sciences (IR)
Publication Details
- Journal
- JGH Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/jgh3.70020
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Jiroft